Looking back and looking ahead: A momentous (and misguided) time for drug pricing policy
August was a momentous month for the life sciences ecosystem, and September looks to be just as significant. In this blog post, we want...
top of page
Incubate Coalition
Aug 15
Incubate responds to Maximum Fair Prices for first 10 drugs selected for Medicare price controls
WASHINGTON (August 15) -- Today, the Biden administration announced Maximum Fair Prices (MFPs) for the first 10 drugs selected for...
Incubate Coalition
Jun 13
Incubate Launches Life Science Investment Tracker to Analyze Impact of the Inflation Reduction Act
WASHINGTON (June 13) -- Today, Incubate launched the Life Science Investment Tracker, a database monitoring changes in investment,...
Incubate Coalition
Feb 7
Incubate Submits Letter On HELP Committee Hearing
Incubate is an international coalition of life science venture capitalists committed to educating policymakers on the role of venture...
Incubate Coalition
Feb 1
Life Sciences Investors Applaud Bipartisan Bill To Eliminate Small-Molecule Penalty
This bipartisan legislation would eliminate the small-molecule penalty by aligning the price-setting timeline for small and large...
Incubate Coalition
Dec 7, 2023
Life Sciences Investors React To Biden Administration’s March-In Decision
After a nine-month review, the Biden administration has reached the unprecedented and misguided conclusion that the 1980 Bayh-Dole Act...
Incubate Coalition
Nov 20, 2023
What Is Up For Biopharmaceutical Policy In 2024?
Incubate and DLA Piper invite you to join us on the morning of Sunday, January 7th, as part of JPM Week 2024. Attendees will gain an...
Incubate Coalition
Oct 12, 2023
Mary R. Grealy On The Small Molecule Penalty, U.S. Dominance In Life Sciences, And More
Incubate Executive Director John Stanford sat down this week with Mary R. Grealy, CEO of the Healthcare Leadership Council, to discuss...
Incubate Coalition
Sep 26, 2023
Incubate Releases Statement On Fitch Ratings’ Analysis Of Medicare Drug Price Negotiations
Fitch Ratings recently released an analysis showing that Medicare's drug price negotiation program is expected to deter investments into...
Incubate Coalition
Aug 29, 2023
Life Sciences Investors React To First 10 Drugs Selected For Government Price Controls
Executive Director John Stanford issued a statement in response. WASHINGTON, D.C. (August 29,2023) — Today, the Centers for Medicare &...